Pharvaris N.V. (PHVS)
D
Pipeline Grade
Drug Pipeline (0 Assets)
No drugs indexed yet. Pipeline data is populated from ClinicalTrials.gov and openFDA.
Upcoming Catalysts
| Date | Event | Drug |
|---|---|---|
| 2026-08-01 | Phase3 Readout | — |
| 2027-06-01 | Phase3 Readout | — |
| 2027-06-01 | Phase3 Readout | — |
Active Clinical Trials (5)
| NCT # | Title | Phase | Status | Enrollment |
|---|---|---|---|---|
| NCT05834777 | Prevention of Intradialytic Hypotension by Inhibiting Bradykinin B2 Receptor | PHASE3 | Recruiting | 26 |
| NCT06679881 | Long-Term, Open-label Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in ... | PHASE3 | Recruiting | 170 |
| NCT05396105 | Extension Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema | PHASE3 | Enrolling By Invitation | 150 |
| NCT06669754 | Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents and Adults... | PHASE3 | Active Not Recruiting | 81 |
| NCT07266805 | Study of Oral Deucrictibant XR Tablet for Prophylaxis and Deucrictibant IR Capsule for On-Demand Treatment of Angioedema... | PHASE3 | Recruiting | 32 |
Source: ClinicalTrials.gov. Trial status last updated by sponsor — may not reflect current state.